Discontinuation report RAN-TADALAFIL

Last updated on 2019-11-26 History
Report ID 99760
Drug Identification Number 02452081
Brand name RAN-TADALAFIL
Common or Proper name RAN-TADALAFIL
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status DORMANT
Active Ingredient(s) TADALAFIL
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-11-15
Remaining supply date 2019-11-15
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-11-26 French Compare
v1 2019-11-26 English Compare

Showing 1 to 2 of 2